Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the USA / NCT07256587
Enrolling by invitation Not applicable

Morning Water Study

NCT07256587 · tracked via the Priya Life Science USA tracker
Sponsor
Efforia, Inc
Phase
Not applicable
Started
2025-08-23
Last updated
2025-12-23

Condition(s) studied

Energy

Investigational drug(s) / intervention(s)

Drink 24 ounces of water

Drink 24 ounces of water: Participants are asked to drink 24 ounces of water first thing upon waking in the morning for 30 days.

Study summary

This study aims to determine the efficacy of morning water consumption on reducing fatigue and boosting daily productivity. Participants will receive personalized feedback on how their morning hydration influences their energy levels, enabling them to make informed decisions on optimizing their daily performance for a more energized life.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * all individuals over the age of consent Exclusion Criteria: * Individuals with Hyponatremia * Individuals with Kidney Issues * Individuals with Gastrointestinal Disorders * Individuals in Occupations with Limited Bathroom Access * Individuals with Fluid Restrictions * Individuals Prone to Electrolyte Imbalance

Primary outcome measure(s)

  • PROMIS Short Form v1.0 - Fatigue 8a — Baseline and 30 days
    PROMIS Short Form v1.0 - Fatigue 8a
  • Neuro-QOL Item Bank v1.0 -Fatigue - Short Form — Baseline and 30 days
    Neuro-QOL Item Bank v1.0 -Fatigue - Short Form

Trial sites (1)

FacilityCityRegionStatus
Efforia New York New York

More Efforia, Inc trials in the USA

See the Impact Beem's Blue Light Therapy Has on Your Skin Health! Recruiting
MyVitalC: Sleep and Everyday Headache Management Recruiting
The Effects on Sleep Quality of 1:4 Reishi Liquid Extract Recruiting
30 Day Insulin Balance Metabolic Health Optimization Protocol Recruiting
Tune Up Your Back: Soundwave Wellness Study Enrolling by invitation

Other trials for the same condition

Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07256587 on ClinicalTrials.gov ↗ ← All trials in the USA